Journal article · 2025 · Open access

A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan

Yasuo Hamamoto, Akihiko Inagawa, Tsunehisa Yamamoto, Hiroaki Ito, Hiroki Matsumoto

Esophagus, 22(4), 574–582 · Published 21 July 2025 · DOI 10.1007/s10388-025-01143-6

Open PDFView at the publisherCite this paper

In brief

“A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan” is a 2025 journal article by Yasuo Hamamoto and 4 co-authors, published in Esophagus. OpenAlex counts 1 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Esophagus.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.51
References
35
Authors
5

Abstract

BACKGROUND: Treatment options for esophageal cancer (EC) are increasingly diverse and complicated. We conducted a web-based survey on patient preferences regarding systemic drug treatment for EC in Japan. METHODS: We used a discrete choice experiment to determine patients' preferences. Eight relevant attributes and their levels were determined using step-by-step input from patients and EC medical experts. Four attributes were related to efficacy, three to safety, and one to quality of life. Ten choice sets of two hypothetical treatments with independent attribute levels were presented in questionnaires. A multinomial logit model was used to estimate predicted choice probabilities. We calculated means and 95% confidence intervals of preference weights and relative attribute importance (RAI). The primary endpoint was mean RAI; secondary endpoints were attribute trade-offs for the total sample, and mean RAI and attribute trade-offs for subgroups. Eligible patients with EC (undergoing or having undergone treatment) were recruited through commercial panels. RESULTS: We analyzed 149 response sets. Respondents placed the highest relative importance on 1-year overall survival (OS; 31.4%), followed by hospitalization/dosing time (27.3%). Safety attributes, including immune-related adverse events, had relatively little influence (≤ 7.5%). Patients were willing to trade off 17.4% of 1-year OS by changing from hospitalizations and long dosing time to no hospitalization and short dosing times. The subgroup aged ≥ 65 years placed greater importance on quality of life than survival. CONCLUSIONS: We first clarified patients' preferences for EC systemic therapy in Japan, which could provide useful information in EC treatment selection.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hamamoto, Y., Inagawa, A., Yamamoto, T., Ito, H., & Matsumoto, H. (2025). A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan. Esophagus, 22(4), 574–582. https://doi.org/10.1007/s10388-025-01143-6

MLA 9

Hamamoto, Yasuo, et al. “A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan.” Esophagus, vol. 22, no. 4, 2025, pp. 574–582. https://doi.org/10.1007/s10388-025-01143-6.

Chicago

Hamamoto, Yasuo, Akihiko Inagawa, Tsunehisa Yamamoto, Hiroaki Ito, and Hiroki Matsumoto. 2025. “A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan.” Esophagus 22 (4): 574–582. https://doi.org/10.1007/s10388-025-01143-6.

Harvard

Hamamoto, Y. et al. (2025) ‘A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan’, Esophagus, 22(4), pp. 574–582. doi:10.1007/s10388-025-01143-6.

IEEE

Y. Hamamoto, A. Inagawa, T. Yamamoto, H. Ito, and H. Matsumoto, “A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan,” Esophagus, vol. 22, no. 4, pp. 574–582, 2025, doi: 10.1007/s10388-025-01143-6.

BibTeX

@article{hamamoto2025discrete,
  title     = {{A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan}},
  author    = {Hamamoto, Yasuo and Inagawa, Akihiko and Yamamoto, Tsunehisa and Ito, Hiroaki and Matsumoto, Hiroki},
  journal   = {Esophagus},
  year      = {2025},
  volume    = {22},
  number    = {4},
  pages     = {574--582},
  doi       = {10.1007/s10388-025-01143-6},
  url       = {https://doi.org/10.1007/s10388-025-01143-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation

  • esophageal cancer
  • patient preferences
  • treatment preferences
  • systemic therapy
  • relative attribute importance
  • overall survival
  • hospitalization
  • timing of drug administration

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Hamamoto, Y., Inagawa, A., Yamamoto, T., Ito, H., & Matsumoto, H. (2025). A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan. Esophagus, 22(4), 574–582. https://doi.org/10.1007/s10388-025-01143-6

How many times has this paper been cited?

1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Esophagus: sign in and open the PDF from this page.

Who wrote this paper?

Yasuo Hamamoto, Akihiko Inagawa, Tsunehisa Yamamoto, Hiroaki Ito, Hiroki Matsumoto.

What is the DOI of this paper?

10.1007/s10388-025-01143-6, permanently at https://doi.org/10.1007/s10388-025-01143-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.